Get the Stockscreener App
37.95
1.99%
-0.77
Pre-market:
38.00
0.05
+0.13%
Newamsterdam Pharma Company Nv stock is traded at $37.95, with a volume of 563.21K.
It is down -1.99% in the last 24 hours and up +33.44% over the past month.
NewAmsterdam Pharma Co NV is a late-stage biopharmaceutical company with a mission to improve patient care in populations with metabolic diseases where currently approved therapies have not been adequate or well tolerated. Its product, obicetrapib, is a next-generation, oral, low-dose CETP inhibitor that is developed to potentially overcome the limitations of current LDL-C lowering treatments.
See More
Previous Close:
$38.72
Open:
$38.72
24h Volume:
563.21K
Relative Volume:
0.56
Market Cap:
$4.27B
Revenue:
$14.09M
Net Income/Loss:
$-176.94M
P/E Ratio:
-17.65
EPS:
-2.15
Net Cash Flow:
$-141.24M
1W Performance:
+6.24%
1M Performance:
+33.44%
6M Performance:
+98.38%
1Y Performance:
+122.97%
1-Day Range:
$37.50
$39.00
1-Week Range:
$35.21
$39.03
52-Week Range:
$14.06
$41.47
Newamsterdam Pharma Company Nv Stock (NAMS) Company Profile
Name
Newamsterdam Pharma Company Nv
Sector
Industry
Phone
35 206 2971
Address
GOOIMEER 2-35, NARRDEN
Compare NAMS with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
NAMS
Newamsterdam Pharma Company Nv
|
37.95 | 4.36B | 14.09M | -176.94M | -141.24M | -2.15 |
|
VRTX
Vertex Pharmaceuticals Inc
|
425.57 | 107.66B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
651.80 | 68.74B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
456.04 | 58.93B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
818.50 | 50.51B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
189.60 | 41.29B | 447.02M | -1.18B | -868.57M | -6.1812 |
Newamsterdam Pharma Company Nv Stock (NAMS) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Oct-20-25 | Resumed | H.C. Wainwright | Buy |
| Aug-25-25 | Initiated | Wells Fargo | Overweight |
| Jul-17-25 | Initiated | Goldman | Neutral |
| Jun-17-25 | Initiated | Citigroup | Buy |
| Jun-10-25 | Initiated | Stifel | Buy |
| Jun-04-25 | Initiated | Cantor Fitzgerald | Overweight |
| Dec-30-24 | Initiated | H.C. Wainwright | Buy |
| May-15-24 | Initiated | TD Cowen | Buy |
| Mar-14-24 | Initiated | Scotiabank | Sector Outperform |
| Jan-18-24 | Initiated | Guggenheim | Buy |
| Jan-16-24 | Initiated | Piper Sandler | Overweight |
| Oct-30-23 | Initiated | RBC Capital Mkts | Outperform |
View All
Newamsterdam Pharma Company Nv Stock (NAMS) Latest News
How NewAmsterdam Pharma Company N.V. Equity Warrant stock performs in stagflationQuarterly Trade Review & AI Forecast for Swing Trade Picks - newser.com
Is NewAmsterdam Pharma Company N.V. (KH6) stock attractive post correctionMarket Risk Analysis & Pattern Based Trade Signal System - newser.com
How hedge fund analytics apply to NewAmsterdam Pharma Company N.V. stock2025 Valuation Update & High Conviction Buy Zone Alerts - newser.com
How NewAmsterdam Pharma Company N.V. Equity Warrant stock reacts to oil pricesExit Point & Long Hold Capital Preservation Plans - newser.com
Pattern recognition hints at NewAmsterdam Pharma Company N.V. upsideMarket Activity Recap & Daily Technical Forecast Reports - newser.com
Why NewAmsterdam Pharma Company N.V. stock is seen as undervaluedPortfolio Update Summary & Weekly High Return Stock Opportunities - newser.com
Will NewAmsterdam Pharma Company N.V. Equity Warrant stock maintain momentum in 2025Share Buyback & Technical Entry and Exit Tips - newser.com
Can volume confirm reversal in NewAmsterdam Pharma Company N.V. Equity WarrantMarket Rally & Community Verified Watchlist Alerts - newser.com
Visual analytics tools that track NewAmsterdam Pharma Company N.V. Equity Warrant performanceJuly 2025 Intraday Action & Daily Entry Point Alerts - newser.com
Will earnings trigger a reversal in NewAmsterdam Pharma Company N.V. Equity WarrantJuly 2025 Movers & Expert Approved Momentum Ideas - newser.com
Using economic indicators to assess NewAmsterdam Pharma Company N.V. Equity Warrant potential2025 Performance Recap & Fast Momentum Entry Tips - newser.com
Risk adjusted return profile for NewAmsterdam Pharma Company N.V. Equity Warrant analyzed2025 Growth vs Value & Fast Exit and Entry Strategy Plans - newser.com
Key resistance and support levels for NewAmsterdam Pharma Company N.V.July 2025 Opening Moves & Intraday High Probability Alerts - newser.com
How to escape a deep drawdown in NewAmsterdam Pharma Company N.V.M&A Rumor & AI Driven Price Forecasts - newser.com
Can NewAmsterdam Pharma Company N.V. (KH6) stock surprise markets with earnings - newser.com
Using data models to predict NewAmsterdam Pharma Company N.V. Equity Warrant stock movement2025 Top Decliners & AI Driven Stock Reports - newser.com
Why retail investors pile into NewAmsterdam Pharma Company N.V. Equity Warrant stock2025 Year in Review & Free Community Consensus Stock Picks - newser.com
NewAmsterdam Pharma Hits Day High with 8.05% Surge, Strong Intraday Performance - Markets Mojo
Is NewAmsterdam Pharma Company N.V. Equity Warrant stock bottoming outBuy Signal & Fast Moving Stock Watchlists - newser.com
What does recent volatility data suggest for NewAmsterdam Pharma Company N.V. Equity WarrantJuly 2025 Setups & Expert-Curated Trade Recommendations - newser.com
Is NewAmsterdam Pharma Company N.V. stock a good choice for value investorsWeekly Trend Summary & Real-Time Buy Zone Alerts - newser.com
Published on: 2025-11-02 01:19:15 - newser.com
Is NewAmsterdam Pharma Company N.V. (KH6) stock prepared for digital transitionQuarterly Performance Summary & Low Risk High Win Rate Stock Picks - newser.com
How to build a custom watchlist for NewAmsterdam Pharma Company N.V.Earnings Miss & Daily Entry Point Alerts - newser.com
Is NewAmsterdam Pharma Company N.V. stock poised for growthWeekly Investment Summary & Accurate Trade Setup Notifications - newser.com
NewAmsterdam Pharma (NAMS) Is Up 6.2% After Announcing Key Phase 3 Data Reveal at AHA 2025—Has The Bull Case Changed? - simplywall.st
Will NewAmsterdam Pharma Company N.V. stock maintain dividend yieldPortfolio Update Report & Weekly High Conviction Trade Ideas - newser.com
Can NewAmsterdam Pharma Company N.V. stock resist sector downturnsJuly 2025 Review & Consistent Income Trade Ideas - newser.com
Is NewAmsterdam Pharma Company N.V. Equity Warrant stock a top pick in earnings seasonForecast Cut & Daily Profit Focused Screening - newser.com
Will NewAmsterdam Pharma Company N.V. (KH6) stock beat Nasdaq index returnsTrend Reversal & Consistent Growth Stock Picks - newser.com
How NewAmsterdam Pharma Company N.V. stock trades during market volatilityGlobal Markets & Stepwise Trade Execution Plans - newser.com
Volatility clustering patterns for NewAmsterdam Pharma Company N.V.Quarterly Portfolio Report & Entry and Exit Point Strategies - newser.com
Can technical indicators confirm NewAmsterdam Pharma Company N.V. Equity Warrant’s reversalMarket Trend Report & Consistent Income Trade Ideas - newser.com
Newamsterdam Pharma Company Nv Stock (NAMS) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.62%
0.21%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):